ConductScience.org, home

Paper66871

Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff: a preliminary report.

Iwarson S and 6 others. Am J Med Sci, 1975. Cited by 21 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff: a preliminary report. Papers, record 66871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/66871

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff: a preliminary report.
PubMed
Journal
Am J Med Sci
PubMed
Year
1975
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2019-07-16
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iwarson SS
2Kjellman HH
3Ahlmén JJ
4Ljunggren CC
5Eriksson EE
6Selander DD
7Hermodsson SS

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis BMajor topic
Immunization, PassiveMajor topic
Antibody Formation
Hepatitis B Antibodies
Hospital Departments
Humans
Kidney Transplantation
Personnel, Hospital
Renal Dialysis
gamma-Globulins

Source PubMed

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
31,973,017Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.Viruses2020https://conductscience.org/library/papers/31973017PubMed
12,102,547Back to the future: antibody-based strategies for the treatment of infectious diseases.Mol Biotechnol2002https://conductscience.org/library/papers/12102547PubMed
822,594Viral hepatitis, type B.Yale J Biol Med1976https://conductscience.org/library/papers/822594PubMed
723,783Vaccine against hepatitis B--18 months prevention in a high risk setting.Med Microbiol Immunol1978https://conductscience.org/library/papers/723783PubMed
466,862Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers.Clin Exp Immunol1979https://conductscience.org/library/papers/466862PubMed
196,274Recent advances in the identification of hepatitis viruses.Postgrad Med J1977https://conductscience.org/library/papers/196274PubMed
85,514Failure of endoscopic transmission of hepatitis B.Dig Dis Sci1979https://conductscience.org/library/papers/85514PubMed
60,830Passive immunization against exposure to hepatitis B virus in the military: potential and possibilities.Yale J Biol Med1976https://conductscience.org/library/papers/60830PubMed
59,545The use of standard gamma globulin for the prevention of hepatitis B.Am J Dig Dis1976https://conductscience.org/library/papers/59545PubMed
59,544The case for not giving gamma globulin in all exposure to hepatitis B.Am J Dig Dis1976https://conductscience.org/library/papers/59544PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/66871

GET https://conductscience.org/api/papers/v1/66871/authors